Capricor Therapeutics, Inc.
USD19.79
+0.29 (+1.49%)
CEO
Linda Marbán
IPO Date
2007-02-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$19.52
Prev. Close
$19.50
Day Low
$19.00
Day High
$20.16
52W Low
$4.30
52W High
$40.37
Market Cap
$0.90B
Volume
2.17M
| -12.0 |
| 31 Dec 2023 | FY | -44.8% | -88.5% | -98.6% | -37.9% | 0.10 | 1.63 | -5.9 |
| 31 Dec 2022 | FY | -755.1% | -1137.4% | -246.2% | -57.9% | 0.22 | 1.82 | -3.3 |
| 31 Dec 2021 | FY | 100.0% | -8175.9% | -63.8% | -48.4% | 0.09 | 8.82 | -3.4 |
| 31 Dec 2020 | FY | 100.0% | -4401.9% | -48.4% | -39.4% | 0.01 | 11.33 | -3.9 |
| 31 Dec 2019 | FY | -411.6% | -760.4% | -111.7% | -68.8% | 0.00 | 11.74 | -0.6 |
| 31 Dec 2018 | FY | 100.0% | -909.1% | -329.1% | -164.3% | 0.00 | 6.75 | -0.8 |
| 31 Dec 2017 | FY | 100.0% | 91.2% | 21.7% | 14.9% | 0.00 | 9.40 | 15.1 |
| 31 Dec 2016 | FY | -377.5% | -589.6% | 469.8% | -100.3% | -3.47 | 3.70 | -2.6 |
| -11.6 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -29.3% | -19.4% | 0.17 | 3.59 | -3.4 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -24.7% | -19.4% | 0.01 | 4.37 | -4.4 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -19.1% | -15.9% | 0.01 | 6.55 | -4.4 |
| 31 Dec 2024 | Q4 | -30.8% | -63.9% | -4.9% | -4.2% | 0.01 | 7.77 | -17.1 |
| 30 Sept 2024 | Q3 | -422.1% | -555.2% | -18.4% | -13.5% | 0.02 | 4.19 | -10.0 |
| 30 Jun 2024 | Q2 | -214.9% | -277.0% | -95.6% | -28.7% | 0.16 | 1.37 | -3.5 |
| 31 Mar 2024 | Q1 | -126.2% | -199.6% | -53.1% | -19.8% | 0.11 | 1.57 | -5.7 |
| 31 Dec 2023 | Q4 | 17.8% | -6.3% | -3.4% | -1.3% | 0.10 | 1.63 | -43.0 |